CSF amyloid--peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

By Bibl Mirko   Mollenhauer Brit   Lewczuk Piotr   Klafki Hans-Wolfgang   Sparbier Katrin   Smirnov Alexandr   Cepek Lukas   Trenkwalder Claudia   Rüther Eckart   Kornhuber Johannes   Otto Markus   Wiltfang Jens  

Brain, Vol. 129, Iss. 5, 2006-05 ,pp. : 1177-1187

Oxford University Press

Access to resources Recommend Favorite

Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls

By Burton Emma J.  

Brain, Vol. 127, Iss. 4, 2004-04 ,pp. : 791-800

Oxford University Press

Access to resources Recommend Favorite

EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up

By Bonanni Laura  

Brain, Vol. 131, Iss. 3, 2008-03 ,pp. : 690-705

Oxford University Press

Access to resources Recommend Favorite

Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson’s disease and dementia with Lewy bodies

By Power John   Blumbergs Peter  

Acta Neuropathologica, Vol. 117, Iss. 1, 2009-01 ,pp. : 63-73

Springer Publishing Company

Access to resources Recommend Favorite

Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease

By Piggott M.A.   Owens J.   O'Brien J.   Colloby S.   Fenwick J.   Wyper D.   Jaros E.   Johnson M.   Perry R.H.   Perry E.K.  

Journal of Chemical Neuroanatomy, Vol. 25, Iss. 3, 2003-03 ,pp. : 161-173

Elsevier

Access to resources Recommend Favorite